SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about clarification

23 Mar 2024 Evaluate
Granules India has informed that the Company has received a copy of the reports from the proxy firms which it has released as a voting advisory to the institutional investors on the resolutions proposed by the Company in the Postal Ballot Notice dated 19.02.2024 which was disseminated to the Members of the Company on 29.02.2024. On review of the said reports, it enclosed clarification on the special resolution proposed for the appointment of Priyanka Chigurupati (DIN:01793431) as a Whole-time Director of the Company for a term of 5 (five) years.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×